Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Aripiprazole-Associated Dizziness and Unsteady Gait

Risk Factors

  • Older age is a risk factor for increased susceptibility to dizziness and unsteady gait with aripiprazole, with reduced dosing recommended in elderly patients 1, 2
  • Poor metabolizers of cytochrome P450 2D6 are also at increased risk of dizziness and unsteady gait with aripiprazole 1, 2

Clinical Management

  • Consider dose reduction if dizziness or unsteady gait occurs, as recommended by the American College of Clinical Pharmacology 2, 3
  • Use lower doses in older or frail patients to minimize the risk of dizziness and unsteady gait 2, 3